Effection and mechanism of radiosensitivity of non-small cell lung cancer cell line H358 following gefitinib treatment

Chinese Journal of Lung Cancer

Volumn 14, Issue 11, 2011, Pages 841-847

  Deng, Jie ^a   Zhuang, Liang ^a   Chen, Yuan ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

h2ax; Egfr; Gefitinib; H358; Lung neoplasmas

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; HISTONE H2AX;

ARTICLE; CELL SURVIVAL; CLONOGENESIS; CONFOCAL MICROSCOPY; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; PROTEIN EXPRESSION; RADIOSENSITIVITY; WESTERN BLOTTING; X IRRADIATION; X RAY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL NUCLEUS; HUMANS; LUNG NEOPLASMS; PROTEIN KINASE INHIBITORS; QUINAZOLINES; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; RECEPTOR, EPIDERMAL GROWTH FACTOR; X-RAYS;

EID: 81755163137     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2011.11.02     Document Type: Article

References (21)

1. Hayes DN, Monti S, Parmigiani G, et al. Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple in dependent patient cohorts. J Clin Oncol, 2006, 24(31): 5079-5090.
2. Normanno N, De Luca A, Bianco C, et al. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene, 2006, 366(1): 2-16.
3. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, et al. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem, 2004, 71(2): 39-85.
4. Harari PM, Huang SM. Epidermal growth factor receptor modulation of radiation response: preclinical and clinical development. Semin Radiat Oncol, 2002, 12, Suppl 2: 21-26.
5. Milas L, Mason KA, Ang KK. Epidermal growth factor receptor and its inhibition in radiotherapy: in vivo findings. Int J Radiat Biol, 2003, 79(7): 539-545.
6. Cascone T, Morelli MP, Ciardiello F. Small molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer. Ann Oncol, 2006(Suppl 2): ii46-ii48.
7. Rodemann HP, Blaese MA. Responses of normal cells to ionizing radiation. Semin Radiat Oncol, 2007, 17(2): 81-88.
8. Rodemann HP, Dittmann K, Toulany M. Radiation-induced EGFR-signaling and control of DNA-damage repair. Int J Radiat Biol, 2007, 83(11-12): 781-791.
9. Nyati MK, Morgan MA, Feng FY, et al. Integration of EGFR inhibitors with radiochemotherapy. Nat Rev Cancer, 2006, 6(11): 876-885.
10. Cengel KA, Voong KR, Chandrasekaran S, et al. Oncogenic K-Ras signals through epidermal growth factor receptor and wild-type H-Ras to promote radiation survival in pancreatic and colorectal carcinoma cells. Neoplasia, 2007, 9(4): 341-348.
11. McKenna WG, Muschel RJ, Gupta AK, et al. The RAS signal transduction pathway and its role in radiation sensitivity. Oncogene, 2003, 22(37): 5866-5875.
12. Ang KK, Berkey BA, Tu X, et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res, 2002, 62(24): 7350-7356.
13. Krause M, Zips D, Thames HD, et al. Preclinical evaluation of moleculartargeted anticancer agents for radiotherapy. Radiother Oncol, 2006, 80(2): 112-122.
14. Chen DJ, Nirodi CS. The epidermal growth factor receptor: a role in repair of radiation-induced DNA damage. Clin Cancer Res, 2007, 13(22 Pt 1): 6555-6556.
15. Burma S, Chen DJ. Role of DNA-Pk in the cellular response to DNA doublestrand breaks. DNA Repair (Amst), 2004, 3(8-9): 909-918.
16. Das AK, Chen BP, Story MD, et al. Somatic mutations in the tyrosine kinase domain of epidermal growth factor receptor (EGFR) abrogate EGFR-mediated radioprotection in non-small cell lung carcinoma. Cancer Res, 2007, 67(11): 5267-5274.
17. Dittmann K, Mayer C, Fehrenbacher B, et al. Radiation-induced epidermal growth factor receptor nuclearimport is linked to activation of DNA-dependent protein kinase. J Biol Chem, 2005, 280(35): 31182-31189.
18. Bonner JA, Buchsbaum DJ, Russo SM, et al. Anti-EGFR-mediated radiosensitization as a result of augmented EGFR expression. Int J Radiat Oncol Biol Phys, 2004, 59(2 Suppl): 2-10.
19. Rogakou EP, Boon C, Redon C, et al. Megabase chromatin domains involved in DNA double-strand breaks in vivo. Cell Biology, 1999, 146(5): 905-915.
20. Dittmann K, Mayer C, Rodemann HP. Nuclear EGFR as novel therapeutic target: insights into nuclear translocation and function. Strahlenther Onkol, 2010, 186(1): 1-6.
21. Park SY, Kim YM, Pyo H. Gefitinib radiosensitizes non-small cell lung cancer cells through inhibition of ataxia telangiectasia mutated. Mol Cancer, 2010, 9: 222.